Equal-WT
WhaleScore 2.0
?
Nantahala Capital Management is based out of New Canaan. Nantahala Capital Management is a hedge fund with 13 clients and discretionary assets under management (AUM) of $2,470,541,928 (Form ADV from 2023-06-14). Their last reported 13F filing for Q4 2023 included $1,672,570,830 in managed 13F securities
and a top 10 holdings concentration of 57.54%. Nantahala Capital Management's largest holding is SPDR(R) S&P(R) Biotech ETF-SPDR(R) S&P(R) Biotech ETF with shares held of 3,314,400. Whalewisdom has at least 51 13F filings, 32 13D filings, 472 13G filings, and 12 Form 4 filings
2023-12-31
Top Buys (13F)
Name | % Change |
---|---|
XBI SPDR(R) S&P(R) Biote (PUT) | 11.77% |
SLNO Soleno Therapeutics | 5.88% |
COST Costco Co. (PUT) | 2.76% |
EOLS Evolus Inc | 1.5% |
RMBL RumbleON Inc | 1.31% |
2023-12-31
Top Sells (13F)
Name | % Change |
---|---|
KRE SPDR(R) S&P Regional (PUT) | 2.14% |
IMAX IMAX Corp | 2.14% |
ESTA Establishment Labs H (CALL) | 1.58% |
CASH Meta Financial Group | 1.51% |
LXFR Luxfer Holdings PLC | 1.4% |
2023-12-31
13F Holdings Summary
Name | $ Change |
---|---|
XBI SPDR(R) S&P(R) Biote | 17.69% |
IWM iShares Russell 2000 | 15% |
SLNO Soleno Therapeutics | 6.87% |
ESTA Establishment Labs H | 3.82% |
CASH Meta Financial Group | 3.35% |
2023-12-31
13F Activity
Market Value | $1.67b, Prior: $1.17b |
New Purchases | 15 stocks |
Added To | 40 stocks |
Sold out of | 20 stocks |
Reduced holdings in | 54 stocks |
Top 10 Holdings % | 57.54% |
Turnover %[1] | 27.34% |
Turnover Alt %[2] | 7.05% |
Time Held Top 20 | 6.55 quarters |
Time Held Top 10 | 7.3 quarters |
Time Held All | 7.54 quarters |
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
2023-12-31
13F Sector Allocation Over Time
2023-12-31
Analysis
Top 20 equal-weighted holdings. Performance numbers calculated through 2023-12-31